Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1955-1963

  Wang, Hsien Yi ^a   Tian, Yu Feng ^a,b   Chien, Chih Chiang ^a   Kan, Wei Chih ^a   Liao, Pao Chi ^c   Wu, Hsin Yi ^c   Su, Shih Bin ^a,d   Lin, Ching Yih ^a,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Peritoneal dialysate; Peritoneal dialysis; Proteomic analysis; Two dimensional gel electrophoresis

Indexed keywords

ALPHA 2 GLOBULIN; COMPLEMENT COMPONENT C4A; HAPTOGLOBIN; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSATE; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MEMBRANE PERMEABILITY; NUCLEOTIDE SEQUENCE; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ALPHA-MACROGLOBULINS; ASCITIC FLUID; BIOLOGICAL MARKERS; BLOTTING, WESTERN; COMPLEMENT C4A; DIABETIC NEPHROPATHIES; DIALYSIS SOLUTIONS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; VITAMIN D-BINDING PROTEIN;

EID: 77952981105     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp696     Document Type: Article

References (43)

1. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957
2. Sitter T, Sauter M. Impact of glucose in peritoneal dialysis: saint or sinner? Perit Dial Int 2005; 25: 415-425
3. Brauner A, Hertting O, Alkstrand E et al. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1. Perit Dial Int 2003; 23: 5-13
4. Maurer MH. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev 2008, in press
5. Liu Y, Yang M, Liu P et al. Proteomic analysis of pericardial effusion: characteristics of tuberculosis-related proteins. Proteomics Clin Appl 2008; 2: 458-466
6. Tyan YC, Wu HY, Su WC et al. Proteomic analysis of human pleural effusion. Proteomics 2005; 5: 1062-1074
7. Tyan YC, Wu HY, Lai WW et al. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chroma-tography tandem mass spectrometry. J Proteome Res 2005; 4: 1274-1286
8. Tan LB, Chen KT, Tyan YC et al. Proteomic analysis for human urinary proteins associated with arsenic intoxication. Proteomics Clin Appl 2008; 2: 1087-1098
9. Bennett MR, Ravipati N, Ross G et al. Using proteomics to identify preprocedural risk factors for contrast induced nephropathy. Proteo-mics Clin Appl 2008; 2: 1058-1064
10. Tyan YC, Guo HR, Liu CY et al. Proteomic profiling of human urinary proteome using nano-high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Chim Acta 2006; 579: 158-176
11. Raaijmakers R, Pluk W, Schroder CH et al. Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis. Nephrol Dial Transplant 2008; 23: 2402-2405
12. Tyan YC, Liao PC. Proteomics analysis of effusion fluids: pleu-ral, pericardial and peritoneal. Proteomics Clin Appl 2007; 1: 834-844
13. Sritippayawan S, Chiangjong W, Semangoen T et al. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res 2007; 6: 4356-4362
14. Ferrero S, Gillott DJ, Remorgida Vet al. Peritoneal fluid proteome in women with different ASRM stages of endometriosis. Gynecol En-docrinol 2008; 24: 433-441
15. Joffe P, Heaf JG. Vitamin D and vitamin-D-binding protein kinetics in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 281-284 (Pubitemid 20026337)
16. Mathieu C, Gysemans C, Guilietti A et al. Vitamin D and diabetes. Diabetologia 2005; 48: 1247-1257
17. Daiger SP, Scahnfield MS, Cavalli-Sforza LL. Human group-specific component (Gc) proteins bind vitamin D and 25-hydroxy-vitamin D. Proc Natl Acad Sci USA 1975; 72: 2076-2080
18. Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-515
19. Iyengar S, Hamman RF, Marshall JA et al. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 1989; 6: 691-698
20. Nyomba BL, Bouillon R, Lissens W et al. 1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 1985; 116: 2483-2488
21. Aloni Y, Shany S, Chaimovitz C. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Miner Electrolyte Metab 1983; 9: 82-86
22. Norman AW, Frankel BJ, Heldt AM et al. Vitamin D deficiency inhibits pancreatic secretions of insulin. Science 1980; 209: 823-825
23. Tanaka Y, Seino Y, Ishida M et al. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol 1984; 105: 528-533
24. Kumar S, Davies M, Zakaria Y et al. Improvement in glucose tolerance and b-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 1994; 70: 440-443
25. Boucher BJ, Mannan N, Noonan K et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995; 38: 1239-1245
26. Hess JR. Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 277-289
27. Ogden JE, Parry ES. The development of hemoglobin solutions as red cell substitutes. Int Anesthesiol Clin 1995; 33: 115-129
28. Alayash AI, Cashon RE. Hemoglobin and free radicals: implications for the development of a safe blood substitute. Mol Med Today 1995; 1: 122-127
29. Zuckerman SH, Doyle MP, Gorczynski R. Preclinical biology of re-combinant human hemoglobin, rHb1.1. Artif Cells Blood Substit Im-mobil Biotechnol 1998; 26: 231-257
30. Yew KL, Andrew J, Azhar BA et al. Haptoglobin reduces renal oxi-dative DNA and tissue damage during phenylhydrazine-induced he-molysis. Kidney Int 2000; 58: 1033-1044
31. Argiles A, Mourad G, Axelrud-Cavadore C et al. High-molecular-mass proteins in haemodialysis-associated amyloidosis. Clin Sci (Lond) 1989; 76: 547-552
32. Coles GA, Topley N. Long-term peritoneal membrane changes. Adv Ren Replace Ther 2000; 7: 289-301
33. Barrington R, Zhang M, Fischer M et al. The role of complement in inflammation and adaptive immunity. Immunol Rev 2001; 180: 5-15
34. Young GA, Kendall S, Brownjohn AM. Complement activation during CAPD. Nephrol Dial Transplant 1993; 8: 1372-1375
35. Reddingius RE, Schroder CH, Daha MR et al. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 1995; 15: 49-53
36. Barbano G, Cappa F, Prigione I et al. Peritoneal mesothelial cells produce complement factors and express CD59 that inhibits C5b-9-mediated cell lysis. Adv Perit Dial 1999; 15: 253-257
37. O'Neill GJ, Yang SY, Dupont B. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA 1978; 75: 5165-5169
38. Tang S, Leung JC, Chan LY et al. Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid. Clin Exp Immunol 2004; 136: 85-94
39. Broche F, Tellado JM. Defense mechanisms of the peritoneal cavity. Curr Opin Crit Care 2001; 7: 105-116
40. Jones S, Holmes CJ, Mackenzie RK et al. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 2002; 13: S97-S103
41. Mackenzie RK, Topley N, Neubauer A et al. Staphylococcal exopro-ducts down-regulate cyclooxygenase 1 and 2 in peritoneal macro-phages. J Lab Clin Med 1997; 129: 23-34
42. Erdei A, Fust G, Gergely J. The role of C3 in the immune response. Immunol Today 1991; 12: 332-337
43. Arason GJ, Geirsson AJ, Kolka R et al. Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis. Ann Rheum Dis 2002; 61: 257-260